Innovative Eyewear Inc. (LUCY)vsResMed Inc (RMD)
LUCY
Innovative Eyewear Inc.
$0.84
-2.03%
HEALTHCARE · Cap: $7.87M
RMD
ResMed Inc
$235.29
+0.11%
HEALTHCARE · Cap: $30.78B
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 165593% more annual revenue ($5.65B vs $3.41M). RMD leads profitability with a 27.0% profit margin vs -225.3%. RMD earns a higher WallStSmart Score of 67/100 (B-).
LUCY
Avoid33
out of 100
Grade: F
RMD
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+23.1%
Fair Value
$1.43
Current Price
$0.84
$0.59 discount
Margin of Safety
-21.1%
Fair Value
$214.32
Current Price
$235.29
$20.97 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 74.5% year-over-year
Conservative balance sheet, low leverage
Strong operational efficiency at 30.9%
Safe zone — low bankruptcy risk
Every $100 of equity generates 23 in profit
Keeps 27 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Generating 1.6B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -102.4% — below average capital efficiency
Negative free cash flow — burning cash
2.4% earnings growth
Comparative Analysis Report
WallStSmart ResearchBull Case : LUCY
The strongest argument for LUCY centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 74.5% demonstrates continued momentum.
Bull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.0% and operating margin at 30.9%. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : LUCY
The primary concerns for LUCY are EPS Growth, Market Cap, Return on Equity.
Bear Case : RMD
The primary concerns for RMD are EPS Growth.
Key Dynamics to Monitor
LUCY profiles as a hypergrowth stock while RMD is a mature play — different risk/reward profiles.
LUCY carries more volatility with a beta of 2.74 — expect wider price swings.
LUCY is growing revenue faster at 74.5% — sustainability is the question.
RMD generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
RMD scores higher overall (67/100 vs 33/100), backed by strong 27.0% margins. LUCY offers better value entry with a 23.1% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Innovative Eyewear Inc.
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Innovative Eyewear Inc. (LUCY) stands at the forefront of the smart eyewear sector, merging advanced technology with appealing aesthetics to meet the needs of modern, tech-savvy consumers. Its flagship product line, Lucyd, is designed to provide integrated audio features and seamless connectivity, offering a blend of convenience and style. Firmly focused on enhancing user experience and driving innovation, LUCY is well-positioned to leverage the growing demand for multifunctional eyewear, creating significant growth opportunities in a rapidly evolving market. As the trend towards smart, connected devices accelerates, LUCY’s strategic initiatives to promote its product offerings place it in a strong position for long-term competitiveness and success.
ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?